Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin

MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion into Wisconsin with the installation of its first Aquadex SmartFlow® systems at a leading pediatric healthcare institution. The installation further expands the Company's growing presence in pediatric critical care at one of the region's premier academic medical centers.

"Establishing our first pediatric program in Wisconsin reflects the continued momentum of our pediatric growth and increasing clinical adoption of our Aquadex therapy and entry into a key market facilitating continued growth in our largest customer category," said Nuwellis’ CEO Mike McCormick. "Leading pediatric hospitals continue to recognize the importance of precise fluid management for critically ill children. This collaboration provides an opportunity to establish clinical protocols and workflows that can support broader utilization of Aquadex therapy over time while strengthening our presence in another important pediatric market."